1/364
Looks like no tags are added yet.
% of body weight blood? + avg L amount
8%, avg is 4.5-6 L
cell component and plasma %
cell components: 45%
plasma: 55%
blood cell components
erythrocytes (RBCs)
leukocytes (WBCs)
thrombocytes (platelets)
plasma components
pale yellow fluid (liquid extracellular matrix)
92% water, 8% proteins (albumin, fibrinogen, globulins)
WBCs + %
neutrophils, 60-70
lymphocytes, 20-25
monocytes, 3-8
eosiniphils, 2-4
basophils, 0.5-1
proteins + %
albumin, 54
globulin, 38
fibrinogen, 7
other, 1
regular amount of platelets
150,000-400,000
regular amount of WBCs
5000-10,000
regulr amount of RBCs
4.8-5.4 million
functions of blood
transport O2, CO2, hormones, nutrients, and metabolic waste products
regulate body temp and acid base balance
carry cells and antibodies that fight infection
centrifugation
process of separating blood into its component parts
performed in the lab before blood testing
components of blood + %
plasma - 55%, least dense
buffy coat (leukocytes + platelets), <1%
erythrocytes - 45% (hematocrit), most dense
what are WBCs
immune cells that protect body against infections, foreign substances, and disease
WBC classification
granular = contain vesicles that appear when cells are stained
neutrophils, eosiniphils, basophils
agranular = have no granules
lymphocytes, monocytes
neutrophils
most abundant WBC
destroy bacteria through phagocytosis
eosinophils
fight parasites
involved in allergic reactions
basophils
release histamine and heparin
participate in inflammation and allergic responses
monocytes
circulate in the bloodstream
macrophags
form when monocytes enter tissues, engulf pathogens (phagocytosis)
T cells
coordinate immune response
B cells
produce immunoglobulins
NK cells
part of innate immunity
hematopoiesis
formation and development of all types of blood cells in the body
pluripotent stem cells give rise to…
lymphoid stem cells and myeloid stem cells
leukopoiesis
process of producing WBCs in bone marrow
myeloid stem cells produce granulocytes and monocytes
lymphoid stem cells produce T cells, B cells, and NK cells
hematopoietic growth factors
hormone-like regulatory molecules that help in the survival, differentiation, and proliferation of progenitor cells, as well as the functional activation of mature cells
lineage specific hematopoietic growth factors (specific WBC type)
granulocyte colony-stimulating factor - stimulates the production of neutrophils
macrophage colony-stimulating factor - stimulates the development of monocytes and macrophages
interleukin-5 (IL-5) - promotes the growth and development of eosinophils
interleukin 7 (IL-7) - supports the development of lymphocytes, especially B and T cells
differential WBC count
measures the percentage and absolute number of each type of leukocyte in the blood
shift to the left
refers to an increase in immature neutrophils (bands) in peripheral blood - indicates that bone marrow is releasing neutrophils early in response to increased demand
normal neutrophil maturation
myeloblast
promyelocyte
myelocyte
metamyelocyte
band neutrophil
segmented (mature) neutrophil
during left shift, bone marrow releases more…
band neutrophils (most common)
occasionally metamelanocytes and myelocytes in severe cases
lymphatic system parts
lymphatic vessels
lymph nodes
lymphoid tissues
thymus
spleen
major functions of lymphatic system
defends body against pathogens
produces and matures lymphocytes
filters lymph and blood
supports adaptive (specific) immunity
categories of lymphoid tissue
primary, secondary
primary lymphoid tissue
where lymphocytes become mature and immunocompetent
bone marrow: site of development of lymphocyte progenitor cells and maturation of immature B cells
thymus: site of maturation of immature T cells
secondary lymphoid tissue
where lymphocytes are activated by antigens
lymph nodes: site of filtration of lymph
spleen: white pulp contains concentrated areas of B cells and T cells, where red pulp contains venous sinuses that filter blood by removing pathogens and senescent erythrocytes
MALT: non-encapsulated lymphoid tissue in the GI tract, respiratory tract, and genitourinary system
non-neoplastic disorders
non-malignant disorders of the WBCs are more common than malignant
some disorders affect the count of a single type of WBC, whereas others affect the counts of multiple or all 5 types of WBCs
common disorders involve changes in the neutrophil or lymphocyte count
suffix -penia
decreased number of cells
suffix -cytosis
increased number of cells
absolute neutrophil count
actual number of neutrophils circulating in the blood
segs + bands x WBC / 100 = ANC
WBC = total WBC count
segs = % mature neutrophils
bands = % immature neutrophils
leukopenia
decrease in the total number of WBCs in the blood
most commonly involves neutrophils, leading to neutropenia
neutropenia
abnormally low number of neutrophils in blood
ANC <1000/microL
normal: 2000-7000/microL
increased risk of infection
agranulocytosis
nearly complete absence of neutrophils
extremely high risk of life-threatening infection
count less than 100
types of neutropenia
congenital and acquired
congenital neutropenia
present at birth due to genetic disorders affecting neutrophil production
acquired neutropenia
develops later in life due to chemo therapy, viral infections, autoimmune diseases, bone marrow disorders
neutropenia characteristics
patients become more prone to recurent infections (usually bacterial or fungal)
common features:
frequent or recurrent infections
fever - may be the only sign
neutropenia treatment
antimicrobial agents, specific hematopoietic growth factors
neutrophilic leukocytosis (granulocytosis)
abnormally increased total WBC count caused mainly by increase in neutrophils (more than 7500/microL, normal 2000-7000)
most common cause: bacterial infections (evident in first stage of infection or inflammation
other causes: inflammation, corticosteroid use, certain blood cancers, such as leukemia
if need for neutrophils increases beyond the supply, then immature neutrophils are released into the blood
premature release of immature leukocytes is termed “shift to the left”
lymphocytopenia (lymphopenia)
an abnormally low number of lymphocytes in the blood (less than 1000, normal is 1000-4500)
patients become more prone to recurrent infections (initial infections may not be fully eliminated, allowing pathogens to persist and cause repeated infections)
common causes of lymphopenia
inherited genetic disorders
chemotherapy and radiation therapy
viral infections (HIV destroys CD4 cells)
treatment for lymphopenia
antimicrobial agents, IV immunoglobulins
lymphocytic leukocytosis
increased WBC count caused mainly by an increase in lymphocytes
more than 4500 micro/L (normal is 1000-4500)
treatment focuses on underlying cause
common causes of lymphocytic leukocytosis
infectious mononucleosis (most common)
chronic immune mediated inflammation (rheumatoid arthritis)
chronic lymphocytic leukemia (CLL)
malignant lymphomas
solid malignant tumors originating in the peripheral lymphoid tissues (typically lymph nodes)
two main categories of malignant lymphomas
hodgkin’s lymphomas (HLs), non-hodgkin’s lymphomas (NHLs)
hodgkin’s lymphomas
originate in a single lymph node or a group of adjacent lymph nodes (often in the neck, chest, or armpits)
non-hodgkin lymphomas
originate in multiple lymph nodes or multiple groups of lymph nodes (often in armpits, chest, abdomen, or groin)
non-hodgkin lymphomas are a heterogenous group of cancers affecting lymphocytes (B, T, NK cells)
originate from lymphocytes at different stages of development
disruption of normal lymphocyte maturation can result in various NHL subtypes
exact cause remains unknown
associated infectious agents (epstein-barr virus and human t=lymphotropic virus type 1)
mature B cell lymphomas
most common subtype of non-hodgkin lymphoma (NHL)
originate from germinal center of B cells or activated B cells that have exited the germinal center
common B cell lymphoma subtypes
follicular lymphoma
indolent (slow growing)
diffuse large B-cell lymphoma (DLBCL)
aggressive, fast-growing, most common between 60-70 years
mantle cell lymphoma
aggressive, characterized by rapid disease progression and poor prognosis
follicular lymphoma
normal lymph node architecture is replaced by malignant lymphoid follicles in a back to back pattern
burkitt lymphoma
highly aggressive B cell non-hodgkin lymphoma (fast growing tumor of the jaw and facial bones)
classified based on geographic distribution
geographic distribution of burkitt lymphoma
endemic (african) - primarily affects children, common in equatorial africa
closely associated with EBV infection: 100% of patients with endemic african burkitt lymphoma show evidence of previous EBV infection
sporadic - occurs worldwide (less frequently associated with EBV)
clinical manifestations of NHL
localized or generalized painless lymphadenopathy
nodal enlargement and transformation over months or years
retroperitoneal and abdominal masses with symptoms of abdominal fullness and back pain
asicites (fluid in peritoneal cavity) and leg swelling
diagnostic tests for NHL manifestations
biopsy is primary means of diagnosis
hodgkin lymphoma
distinguished by the presence of an abnormal reed-sternberg cell
hallmark feature used to diagnose hodgkin lymphoma
commonly in 2 age groups
young adults (15-40)
older adults (55+)
clinical manifestations of hodgkin lymphoma
enlarged painless neck lymph nodes (usually begins in a single lymph node or chain of nodes)
lymphadenopathy, causing pressure or obstruction
mediastinal mass
fever, weight loss, night sweats, pruritus, fatigue
description of classic reed-sternberg cells
mirror image nuclei “owl’s eye” two large nuclear lobes, each with a prominent red nucleolus surrounded by a clear halo
staging of hodgkin lymphoma
cancer found in 1 lymph node region or one lymphoid organ (spleen or thymus)
stage II HL
cancer involves two or more lymph node regions on same side of diaphragm (either above or below)
may also involve nearby extranodal site
stage III HL
cancer is present in lymph node regions on both sides of diaphragm
may also involve the spleen or nearby extranodal organ
stage IV HL
cancer has spread widely to one or more extranodal organs, such as bone marrow, liver, lungs, bones
leukemias facts
malignant neoplasms of hematopoietic precursor cells
characterized by uncontrolled growth of immature white blood cells
these abnormal cells replace normal bone marrow cells, affecting blood cell production
apprx 60,000-62,000 new cases diagnosed annually
most common cancer in children and teens
accounts for apprx 29% of childhood cancers
history of leukemia
means “white blood”
first used by rudolf virchow
described the abnormal increase in WBCs compared with RBCs
classification of leukemias
by predominant cell type, disease progression, and french-american-british classification
predominant cell type - leukemia
lymphocytic (lymphoid)
myelogenous (myeloid)
disease progression - leukemias
acute (rapid onset)
chronic (slow progression)
french american british classification - 4 major types of leukemia
ALL - acute lymphocytic (lymphoblastic) leukemia
CLL - chronic lymphocytic leukemia
AML - acute myelogenous (myeloblastic) leukemia
CML - chronic myelogenous leukemia
acute leukemia
presence of undifferentiated or immature cells, usually blast cells
sudden onset, rapid progression with short survival
symptoms severe and develop quickly
chronic leukemia
predominant cell is mature but does not function normally
slow, gradual onset with slow progression
symptoms mild or absent initially - develop over months/years
lymphocytic leukemias (origin, common sites of infiltration, clinical consquences)
origin
develop from immature lymphocytes and their precursor cells in the bone marrow
common infiltration sites
spleen
lymph nodes
CNS
clinical consequences
impairs normal immune function and lymphocyte production
myelogenous leukemias (origin, interferes with maturation of…, clinical consequences)
origin
arise from pluripotent myeloid stem cells in bone marrow
interferes with maturation of
granulocytes
erythrocytes
thrombocytes
clinical consequences
increased risk of infections
anemia
bleeding tendencies
etiology of leukemia
exact cause largely unknown - develops due to genetic and environmental factors
molecular basis of leukemia
develops due to disruption of genes and chromosomal abnormalities controlling blood cell development, growth and survival
leads to uncontrolled production of abnormal blood cells
molecular research improvement for leukemia
diagnosis and classification into specific subtypes
targeted treatment selection
monitoring of treatment response and disease progression
acute lymphocytic leukemia (ALL)
most common childhood leukemia
greater than 30% lymphoblasts in bone marrow or blood
predisposing factors: radiation exposure, previous chemo, genetic disorders (Down’s), age
most common ages 2-5
acute myelogenous leukemia (AML)
most common adult leukemia (50+)
greater than 20% myeloblasts in bone marrow or blood
predisposing factors: exposure to radiation, benzene, and chemo
common manifestations of ALL and AML
fatigue due to anemia
low grade fever and night sweats
weight loss
easy bruising and bleeding due to thrombocytopenia
bone pain and tenderness from bone marrow expansion
frequent infections caused by neutropenia
physical findings of ALL and AML
lymphadenopathy - enlargement of lymph nodes bc of infiltration by leukemic cells
splenomegaly and hepatomegaly - enlargement of spleen + liver
complications of acute leukemia (3)
leukostasis
CNS
hyperuricemia
leukostasis
blast cell count exceeds apprx 100,000 cells/microL, causing increased blood viscosity
immediate treatment required
leukapheresis to remove excess blast cells and prevent organ damage
central nervous system involvement (acute leukemia)
leukemic cells can cross the blood-brain barrier and infiltrate the CNS
hyperuricemia
abnormally high level of uric acid in blood
rapid destruction of leukemic cells during chemotherapy result in release of purine nucleotides increased uric acid production
diagnostic tests for acute leukemia
peripheral blood smear; bone marrow tests
treatment for acute leukemia
chemotherapy
supportive measures (blood transfusions, antibiotics, antifungals, antivirals)
stem cell transplantation
bone marrow transplant
chronic lymphocytic leukemia
affects monoclonal B lymphocytes
most common leukemia in adults in the Western world
disease progression: indolent or aggressive
indolent CLL progression
slow-progressing form
often asymptomatic
discovered incidentally on routine complete blood count
aggressive CLL progression
fast progressing form
enlarged lymph nodes, spleen, liver
fatigue, fever and weight loss
chronic myelogenous leukemia
begins when a single pluripotent hematopoietic stem cell acquires a genetic mutation
nearly all patients have the philadelphia chromosome caused by reciprocal translocation between chromosomes 9 and 22
cells affected by CML
granulocytes (predominant leukemic cells), erythroid precursors, megakaryocytes